Paradigm Biopharmaceuticals Ltd is a late-stage clinical development company engaged in the research and development of therapeutic products for human use in Australia... Show more
Industry Biotechnology
A.I.dvisor tells us that PBIGF and PSTV have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PBIGF and PSTV's prices will move in lockstep.
| Ticker / NAME | Correlation To PBIGF | 1D Price Change % | ||
|---|---|---|---|---|
| PBIGF | 100% | N/A | ||
| PSTV - PBIGF | 27% Poorly correlated | -1.95% | ||
| ENLV - PBIGF | 26% Poorly correlated | N/A | ||
| OXBDF - PBIGF | 7% Poorly correlated | +30.63% | ||
| PTCHF - PBIGF | 6% Poorly correlated | -4.85% | ||
| NTRB - PBIGF | 4% Poorly correlated | +0.40% | ||
More | ||||